Literature DB >> 17166893

Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin).

S K Gibran1, A Sachdev, T Stappler, R Newsome, D Wong, P Hiscott.   

Abstract

AIM: To report the findings in a patient treated by repeated intravitreal bevacizumab (Avastin) injections, followed by macular relocation and excision of subfoveal choroidal neovascular membrane (CNV).
METHODS: Histopathological evaluation of the CNV specimen, including immunohistochemical assessment.
RESULTS: During surgical excision, the CNV seemed to be avascular and its underlying bed did not bleed. Histopathological examination revealed that the CNV comprised avascular fibrous subretinal tissue containing fibroblastic retinal pigment epithelial (RPE) cells, fragments of irregular thickened Bruch's membrane and fibrotic choroidal tissue containing some medium-sized vessels but no choriocapillaris.
CONCLUSIONS: The development of an RPE tear during the course of Avastin treatment may reflect contraction of the avascular subretinal tissue, whereas the lack of capillaries in both choroidal and subretinal components may be caused by the increased access of Avastin to the choriocapillaris in the presence of the RPE tear.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166893      PMCID: PMC1954763          DOI: 10.1136/bjo.2006.108795

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

Review 1.  Choroidal neovascularization: a wound healing perspective.

Authors:  David Kent; Carl Sheridan
Journal:  Mol Vis       Date:  2003-12-22       Impact factor: 2.367

2.  Macular relocation after photodynamic therapy for recurrent choroidal neovascular membrane: visual results and histopathological findings.

Authors:  P Stanga; P Hiscott; K Li; D Wong
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

3.  Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7.

Authors:  Hans E Grossniklaus; Päivi H Miskala; W Richard Green; Susan B Bressler; Barbara S Hawkins; Cynthia Toth; David J Wilson; Neil M Bressler
Journal:  Arch Ophthalmol       Date:  2005-07

4.  Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization.

Authors:  Nobuo Jo; Carolina Mailhos; Meihua Ju; Eunice Cheung; John Bradley; Kazuaki Nishijima; Gregory S Robinson; Anthony P Adamis; David T Shima
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

5.  Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.

Authors:  Ziad F Bashshur; Ali Bazarbachi; Alexandre Schakal; Zeina A Haddad; Christelle P El Haibi; Baha' N Noureddin
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

6.  Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Authors:  Ryan M Rich; Philip J Rosenfeld; Carmen A Puliafito; Sander R Dubovy; Janet L Davis; Harry W Flynn; Serafin Gonzalez; William J Feuer; Richard C Lin; Geeta A Lalwani; Jackie K Nguyen; Gaurav Kumar
Journal:  Retina       Date:  2006 May-Jun       Impact factor: 4.256

7.  The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.

Authors:  A E Fung; P J Rosenfeld; E Reichel
Journal:  Br J Ophthalmol       Date:  2006-07-19       Impact factor: 4.638

8.  Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration.

Authors:  C H Meyer; S Mennel; J C Schmidt; P Kroll
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

9.  Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.

Authors:  P F Lopez; B D Sippy; H M Lambert; A B Thach; D R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-04       Impact factor: 4.799

  9 in total
  17 in total

Review 1.  Emerging therapeutic approaches in the management of retinal angiogenesis and edema.

Authors:  An Truong; Tien Y Wong; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2010-12-18       Impact factor: 4.599

2.  Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis.

Authors:  Andreas Stahl; Lilija Paschek; Gottfried Martin; Nicolas Feltgen; Lutz L Hansen; Hansjürgen T Agostini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-27       Impact factor: 3.117

3.  Choroidal folds and retinal pigment epithelium tear following intravitreal bevacizumab injection for exudative age-related macular degeneration.

Authors:  Miwako Kawashima; Ryusaburo Mori; Yoshihiro Mizutani; Mitsuko Yuzawa
Journal:  Jpn J Ophthalmol       Date:  2008-04-30       Impact factor: 2.447

4.  Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).

Authors:  David Sarraf; Anthony Joseph; Ehsan Rahimy
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

5.  Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.

Authors:  Joo Youn Shin; Moonjung Choi; Byunghoon Chung; Suk Ho Byeon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-07       Impact factor: 3.117

6.  A new kind of labyrinth-like capillary is responsible for leakage from human choroidal neovascular endothelium, as investigated by high-resolution electron microscopy.

Authors:  Ulrich Schraermeyer; Sylvie Julien; Antje Biesemeier; Karl Ulrich Bartz-Schmidt; Hartwig Wolburg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-22       Impact factor: 3.117

7.  Retinal Pigment Epithelium Tear.

Authors:  Aleksandra V Rachitskaya; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2014-12-06

8.  Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure.

Authors:  Mohammad Dahrouj; Danielle M Desjardins; Yueying Liu; Craig E Crosson; Zsolt Ablonczy
Journal:  Exp Eye Res       Date:  2015-06-10       Impact factor: 3.467

9.  Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens.

Authors:  Noriko Yoshida; Toshio Hisatomi; Yasuhiro Ikeda; Ri-ichiro Kohno; Yusuke Murakami; Hiroyuki Imaki; Akifumi Ueno; Kimihiko Fujisawa; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-13       Impact factor: 3.117

10.  [Serous vascularized pigment epithelial detachment in exudative AMD. Morphological typing and risk of tears in the RPE].

Authors:  B Lehmann; B Heimes; M Gutfleisch; G Spital; D Pauleikhoff; A Lommatzsch
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.